Association between Serum C-Reactive Protein and Benign Prostatic and Patients with Prostatic Cancer Hyperplasia
10.3969/j.issn.1671-7414.2014.05.035
- VernacularTitle:血清C-反应蛋白水平升高与前列腺癌患者的相关性
- Author:
Sha LIN
;
Ying ZHAO
;
Jie ZHANG
- Publication Type:Journal Article
- Keywords:
CRP;
prostatic cancer;
benign prostatic hyperplasia
- From:
Journal of Modern Laboratory Medicine
2014;(5):130-131,134
- CountryChina
- Language:Chinese
-
Abstract:
Objective To explore the association between C reactive protein (CRP)with prostatic cancer (PCa)and benign prostatic hyperplasia (BPH).Methods Retrospective analysis the 110 patients of the First Affiliated Hospital of Zhejiang University In January 2010 to August 2012 whose TPSA>4 ng/ml,postoperative pathology confirmed the diagnosis of 54 cases of prostate cancer,5 6 cases of benign prostatic hyperplasia.Detected serum CRP levels by using transmission turbidim-etry and TPSA levels by using chemiluminescence immunoassay of 54 PCa and 56 BPH patients.According to the Gleason score,PCa patients were divided into high-risk and low-risk PCa two groups,the differences among high-risk PCa,low-risk PCa and BPH groups were analyzed by nonparametric statistics analysis.Results The CRP level of high-risk PCa was 4.20~2.12 mg/L,the CRP level of low-risk PCa was 1.90~0.91 mg/L and the CRP levels in BNP patients was 1.49±0.87 mg/L,the high-risk and low-risk PCa serum CRP level obviously higher than that of patients with BPH,the differences were statistically significant (P<0.05).Conclusion Serum CRP levels of PCa patients were increased significantly,espe-cially in high-risk PCa patients.
